Kylie Price is Chief Technology Officer and Hugh Green Cytometry Fellow at the Malaghan Institute of Medical Research. She has 20 years experience providing strategic, scientific, and operational direction in multidisciplinary environments.
Kylie leads the Hugh Green Cytometry Centre, a team of highly skilled technology scientists in providing supporting to over 80 scientists at the Malaghan Institute. The Hugh Green Cytometry Centre provides access to cutting-edge technology platforms (including flow and spectral cytometry, histology, bioimaging, genomics and bioinformatics), and advises multiple research groups both nationally and abroad.
Kylie also has a strong leadership track-record, organising high profile networking events, such as CYTOAsia Singapore 2017, and directing international organisations, such as the Australasian Cytometry Society of which she is former President (2015-2016). Kylie is a two-time New Zealand Woman of Influence Awards finalist (2014 and 2018) and finalist of the 2021 NZ High Tech Awards. She was the first New Zealander elected to the International Society for Advancement of Cytometry (ISAC) Council (2018-2020) and was elected ISAC Secretary in 2020.
Hugh Green Cytometry Centre Named Cytek® Centre of Research Excellence
3 February 2023
NZ needs action now on nanomedicines hub
20 April 2022
New state-of-the-art cell sorter broadens our potential for discovery
16 December 2021
Taking RNA technology into NZ’s future
19 October 2021
Malaghan cytometry expert appointed to international leadership programme
28 May 2021
Head of Research Technology finalist in NZ Hi-Tech Awards
6 April 2021
Munoz-Erazo L, Shinko D, Schmidt AJ, Price KM (2022). Implementing High Dimensional Reduction Analysis on Histocytometric Data. Curr Protoc. 2(11):e586
Munoz-Erazo L, Schmidt AJ, Shinko D, Price KM (2022). How to Build an Image-Processing Pipeline for Automating Multiparameter Histocytometry Analysis. Curr Protoc. 2(3):e380
Ferrer-Font, L., Small, S. J., Lewer, B., Pilkington, K. R., Johnston, L. K., Park, L. M., Lannigan, J., Jaimes, M. C., & Price, K. M. Panel optimization for high-dimensional immunophenotyping assays using full-spectrum flow cytometry. Current Protocols, 1, e222. 7th September 2021. doi: 10.1002/cpz1.222
Munoz-Erazo, L., Schmidt, A. J., & Price, K. M. High-dimensional image analysis using histocytometry. Current Protocols, 1, e184. June 24th 2021. doi: 10.1002/cpz1.184
Kathleen Daniels, Alexis Conway, Rui Gardner, Lola Martinez, Kylie M. Price, Sarah Schneider, Rachael Sheridan, Jane Srivastava and Sherry Thornton. Remote SRL Staff and User Training in a Global Pandemic. Cytometry Part A, Volume 97, Issue 11, November 11th 2020. doi: 10.1002/cyto.a.24262
Laura Ferrer-Font, Johannes U. Mayer, Sam Old, Ian F. Hermans, Jonathan Irish and Kylie M. Price. High-dimensional data analysis algorithms yield comparable results for mass cytometry and spectral flow cytometry data. Cytometry Part A, Volume 97, Issue 8, April 2020. doi: 10.1002/cyto.a.24016
Laura Ferrer-Font, Christophe Pellefigues, Johannes Mayer, Sam Small, Maria Jaimes and K.M. Price. Panel design and optimization for high‐dimensional immunophenotyping assays using spectral flow cytometry. Current Protocols in Cytometry, March 5th 2020; 92, e70. doi: 10.1002/cpcy.70
Laura Ferrer-Font, Palak Mehta, Phoebe Harmos, Alfonso J Schmidt, Sally Chappell, Kylie M. Price, Ian F. Hermans, Franca Ronchese, Graham le Gros and Johannes U. Mayer. High-dimensional analysis of intestinal immune cells during helminth infection. eLife. February 11th 2020. 2020;9:e51678
Kamila Czechowska, Joanne Lannigan, Nima Agahaeepour, ….Kylie M. Price, …Attila Tarnok. Cyt‐Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference Workshops. Cytometry Part A, December 2019; 95A: 1326-1274. doi 10.1002/cyto.a.23941
Schmidt, A. J., Mayer, J. U., Wallace, P. K., Ronchese, F., & Price, K. M. Simultaneous Polychromatic Immunofluorescent Staining of Tissue Sections and Consecutive Imaging of Up to Seven Parameters by Standard Confocal Microscopy. Current Protocols in Cytometry, September 2019, 91, e64 doi: 10.1002/cpcy.64
Alfonso Schmidt, Tiffany Bouchery, Graham Le Gros and Kylie Price. Large Particle Sorting to Isolate Live Parasitic Nematode Eggs. Current Protocols in Cytometry. April 2016. 76; 11.21.1-11.21.15.
Kylie M. Price, Katharine A. Muirhead and Paul K. Wallace. Proliferation by many other names: Monitoring cell cycle progression and cell division by flow cytometry. Cytometry Part A. March 2016; Volume 89, Issue 3, pages 233–235.
Kylie M Price and Mike Berridge. Laser light illuminates medical research. New Zealand Science Review. September 2015; Vol. 72 (2): 49-53
N J Daniels, E Hyde, S Ghosh K Seo. K M Price, K Hoshino, T Kaisho, T Okada and F Ronchese. Antigen-specific cytotoxic T lymphocytes target airway CD103+ and CD11b+ dendritic cells to suppress allergic inflammation. Mucosal Immunology. June 2015; 9, 229–239.
Ataera H, Hyde E, Price KM, Stoitzner P, Ronchese F. Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells. PLoS One. March 2011; 6(3):e17515.
Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF, McConnell MJ. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells. 2011; 29(3): 452-461.
Alejandra Perea-Blázquez, Kylie Price, Simon K. Davy and James J. Bell. Diet Composition of Two Temperate Calcareous Sponges: Leucosolenia echinata and Leucetta sp. from the Wellington South Coast, New Zealand. The Open Marine Biology Journal. 2010; 4: 65-73.
Dickgreber N, Stoitzner P, Bai Y, Price KM, Farrand KJ, Manning K, Angel CE, Dunbar PR, Ronchese F, Fraser JD, Bäckström BT, Hermans IF. Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy.The Journal of Immunology. February 2009; 182(3):1260-9.
Stoitzner P, Green LK, Jung JY, Price KM, Atarea H, Kivell B, Ronchese F. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells. Cancer Immunology Immunotherapy. November 2008; 57(11):1665-73.
Stoitzner P, Green LK, Jung JY, Price KM, Tripp CH, Malissen B, Kissenpfennig A, Hermans IF, Ronchese F. Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. The Journal of Immunology. February 2008; 180(3):1991-8.
Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L, Ronchese F, Romani N. Langerhans cells cross-present antigen derived from skin. Proceedings of the National Academy of Sciences U.S.A. May 2006; 103(20):7783-8.